GlassScriptPhysician profile
Channing Y Chin
NPI 1285870428
$14,231.92
in general payments reported to CMS, 2019-2025
20 companies · $467 in 2025
The $467 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,375 · 2020: $60.74 · 2021: $258 · 2022: $474 · 2023: $1,743 · 2024: $9,855 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,400 · Education: $4,067 · Food and Beverage: $2,520 · Travel and Lodging: $1,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,400.00 |
| Education | $4,067.23 |
| Food and Beverage | $2,520.35 |
| Travel and Lodging | $1,076.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,217.22 | 2019-2024 | |
| Heron Therapeutics, INC. | $4,571.34 | 2022-2024 | Zynrelef |
| Medtronic, INC. | $1,153.64 | 2021-2025 | Signia, Ligasure |
| Novo Nordisk INC | $607.35 | 2019-2025 | Wegovy |
| Ethicon US, LLC | $449.93 | 2019-2024 | Echelon Flex, Echelon Endopath, Linx Reflux Management System |
| Medical Device Business Services, INC. | $294.05 | 2024 | Linx Reflux Management System |
| Covidien LP | $154.53 | 2019 | |
| Karl Storz Endoscopy-America | $149.99 | 2025 | N.A. |
| W. L. Gore & Associates, INC. | $134.98 | 2025 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Currax Pharmaceuticals LLC | $80.11 | 2022-2025 | Contrave |
| Conmed Corporation | $77.25 | 2024 | Airseal |
| Vertex Pharmaceuticals Incorporated | $70.59 | 2025 | |
| Lilly USA, LLC | $68.00 | 2024-2025 | Zepbound |
| Redhill Biopharma INC. | $52.18 | 2021-2023 | Talicia |
| Endo Pharmaceuticals INC. | $40.96 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apollo Endosurgery US INC | $31.43 | 2019 | |
| Olympus America INC. | $23.92 | 2023 | Olympus |
| Intra-Sana Laboratories | $19.87 | 2021 | |
| Teleflex LLC | $18.71 | 2020 | |
| Boston Scientific Corporation | $15.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Channing Chin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.